The government is in the midst of reviewing the Access to Medicine Regime to determine whether it is the Canadian legislation or other factors that have prevented a single generic pill from being distributed for HIV/AIDS or tuberculosis treatment.
If you are already a subscriber
Subscribe to Embassy
Subscribe to the print and electronic editions and get instant access to Embassy online.
Purchase this week's edition of Embassy in electronic format (PDF) for $4.00
Editor’s Note: Comments that appear on the site are not the opinion of The Embassy. Personal attacks,
name-calling, offensive language, and unsubstantiated allegations are not allowed.
For more information on our commenting policies, please see our Community Discussion Rules page.
If you see a typo or error in a story, report it to us here email@example.com.